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 Abstract    
Objective: The aim of this study was to measure interleukin-6 (IL-6) levels in maternal serum of women undergoing 
preterm labor without a clear infection.
Materials and Methods: Twenty two pregnant women with diagnosis of preterm labor who presented to the 
outpatient clinic of 19 Mayıs University Faculty of Medicine from July 2011 through December 2011 were enrolled 
in the study group. Twenty two healthy pregnant women who were at the same gestational age as the study group 
were selected as the control group. 
Results: Gestational age in the study and control groups varied from 24 weeks and 4 days to 34 weeks and 6 
days. In the study group, 11 patients (50%) underwent preterm birth. Pregnant women in preterm labor were com-
pared to healthy pregnant women with regards to serum IL-6 levels. No significant difference was found in the IL-6 
levels of maternal serum between the 2 groups. 
Conclusion: In this study, we have shown that there is no increase in IL-6 levels in patients undergoing preterm 
labor without clinical or biochemical infection signs. 
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 Streszczenie 
Cel: Celem badania było określenie poziomu interleukiny 6 (IL-6) w surowicy krwi matki u kobiet, które przebyły 
poród przedwczesny bez oczywistej infekcji.
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Introduction
Preterm	 labor	 is	 defined	 as	 labor	 starting	 after	 20	 weeks	
of	 gestation	 and	 before	 37	 weeks	 of	 gestation.	 Preterm	 birth	
complicates	12.7%	of	all	pregnancies	in	the	U.S.	and	is	responsible	
for	75%	of	perinatal	mortality	[1,	2,	3,	4].	
Labor	 involves	 cervical	 effacement	 and	 dilatation	 in	
conjunction	 with	 coordinated	 uterine	 contractions	 that	 are	
maintained	until	the	fetus	and	placenta	are	delivered.	Four	principal	
mechanisms	 are	 emphasized	with	 regards	 to	 the	 occurrence	 of	
preterm	labor.	The	first	highlights	premature	activation	of	normal	
physiological	delivery	mechanisms,	while	the	second	addresses	
excess	uterine	strain.	The	 third	and	fourth	mechanisms	 involve	
inflammation	and	decidual	bleeding,	respectively.	The	underlying	
cause	of	preterm	labor	is	idiopathic	in	50%	of	pregnancies	[5].	At	
present,	many	tests	are	used	for	the	diagnosis	of	preterm	labor,	
since	 there	are	many	causes	 in	 its	 etiology.	 Idiopathic	cases	of	
preterm	labor	are	most	common.	However,	excluding	idiopathic	
cases,	preterm	labor	can	be	related	to	various	obstetric,	medical,	
and	 anatomic	 disorders.	 Preterm	 labor	 is	 directly	 linked	 to	 4	
principal	causes	[5]:
1.	 İnduced	delivery	due	 to	maternal	or	 fetal	 indications	or	
caesarean	section	before	labor
2.	Spontaneous	idiopathic	preterm	labor	without	membrane	
rupture
3.	 Idiopathic	 preterm	 premature	 rupture	 of	 membrane	
(PPROM)
4.	Twins	or	multi-fetal	deliveries	
Interleukin-6	(IL-6)	is	a	protein	which	is	encoded	by	the	IL-6	
gene	[6].	IL-6	functions	as	both	a	pro-inflammatory	and	an	anti-
inflammatory	cytokine.	It	is	released	by	T	cells	and	macrophages	
to	stimulate	the	immune	response	during	infection	or	following	
tissue	damage,	particularly	burns,	which	leads	to	inflammation.	
The	 role	 of	 IL-6	 as	 an	 anti-inflammatory	 cytokine	 is	mediated	
by	inhibitory	effects	on	tumor	necrosis	factor	(TNF)-α	and	IL-1	
and	activation	of	 IL-10.	 It	has	been	proposed	 that	 IL-6	plays	a	
direct	role	in	preterm	labor	[7].	Although	the	causes	of	preterm	
birth	are	multifactorial,	inflammatory	cytokines	may	have	roles	in	
infection,	PPROM,	and	smoking,	which	are	factors	known	to	be	
associated	with	preterm	birth	[8,	9].	
It	is	known	that	IL-6	activates	white	cells	to	invade	the	uterus,	
increases	 the	 expression	 of	 oxytocin	 receptors,	 and	 increases	
prostaglandins	 by	 activating	 the	 hypothalamic-pituitary-adrenal	
(HPA)	axis	[5].
Materials and Methods
1. Study Method and Patient Details
Twenty	 two	 pregnant	 women	 with	 diagnosis	 of	 preterm	
labor	 between	 24	 and	 34	weeks	 of	 gestation	who	 presented	 to	
the	outpatient	clinic	or	were	hospitalized	in	the	inpatient	clinic	of	
the	Gynecology	 and	Obstetrics	Department	of	Ondokuz	Mayıs	
University	Faculty	of	Medicine	were	enrolled	in	the	study	group.	
Twenty	 two	 healthy	 pregnant	 women	 who	 presented	 to	 the	
outpatient	clinic	at	the	same	gestational	age	were	selected	as	the	
control	group.
Education	status	was	not	taken	into	consideration.	Pregnant	
women	 in	 the	 study	 and	 control	 groups	 were	 not	 different	 in	
terms	 of	 smoking	 status,	 alcohol	 consumption,	 or	 illicit	 drug	
addiction	and	did	not	suffer	from	cervical	or	uterine	anomalies,	
heart	disease,	asthma,	diabetes,	liver	disease,	kidney	disease,	or	
connective	tissue	disease.
Diagnosis	of	preterm	delivery	was	based	on	the	occurrence	of	
2	uterine	contractions	in	30	minutes,	in	association	with	cervical	
change	or	significant	effacement	and	dilatation	and/or	occurrence	
of	 symptoms	 such	 as	 pelvic	 compression,	 menstruation-like	
cramps,	 and	 lower	 back	 pain.	 Presence	 of	 contractions	 was	
identified	 in	all	pregnant	women	via	manual	 follow-up	or	non-
stress	test	(NST).
In	 the	 study	 and	 control	 groups,	 week	 of	 gestation	 was	
calculated	 according	 to	 last	 menstrual	 period	 in	 patients	 who	
clearly	 knew	 the	 dates	 of	 their	 last	 menstrual	 cycle	 and	 had	
regular	menstrual	cycles.	Week	of	gestation	was	calculated	with	
regards	to	the	measurement	of	crown-rump	length	in	patients	who	
could	not	 remember	or	were	unclear	 about	 their	 last	menstrual	
period.	All	pregnant	women	with	final	diagnosis	of	preterm	labor	
were	admitted	for	inpatient	treatment	in	our	clinic.
Pregnant	 women	 with	 PPROM	 with>4	 cm	 cervical	
effacement,	pre-eclampsia,	eclampsia,	ablatio	placenta,	placenta	
previa,	 chorioamnionitis,	 intrauterine	 growth	 retardation,	
intrauterine	exitus,	or	Rh	immunization	were	not	included	in	this	
study.	In	addition,	those	with	multiple	fetuses,	diabetes	mellitus,	
hyperthyroidism,	 significant	 heart	 disease,	 prominent	 uterine	
myoma,	significant	cervical	or	uterine	anomalies,	human	immune	
deficiency	 virus	 (HIV)	 or	 other	 significant	 infection,	 evident	
urinary	infection	or	confirmed	urinary	tract	infection,	leucorrhea	
or	other	vaginal	infection	or	vaginal	drainage,	or	uterine	sensitivity	
were	excluded.	Other	exclusion	criteria	included	fetal	tachycardia	
(>	160	beats	per	minute),	maternal	tachycardia	(>	100	beats	per	
Materiał i metoda: Do badania włączono dwadzieścia dwie kobiety z diagnozą porodu przedwczesnego, które 
zgłosiły się do poradni przyszpitalnej przy Mayis University Faculty of Medicine w terminie od lipca 2011 do grudnia 
2011. Grupę kontrolną stanowiły 22 zdrowe kobiety w takim samym wieku ciążowym jak grupa badana.
Wyniki: Wiek ciążowy w obu grupach mieścił się w granicach od 24 tyg+4 dni do 34 tyg+6 dni. W grupie badanej 
11 kobiet (50%) przebyło poród przedwczesny. Kobiet ciężarne, które urodziły przedwcześnie były porównane z 
kobietami zdrowymi, pod względem poziomu IL-6 w surowicy. Nie znaleziono istotnych różnic w poziomie IL-6 w 
surowicy krwi pomiędzy obiema grupami.
Wnioski: Porodowi przedwczesnemu bez klinicznych i biochemicznych objawów infekcji nie towarzyszy wzrost 
poziomu IL-6.
 Słowa kluczowe: poród przedwczesny / Interleukina 6 /
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minute),	maternal	leukocytosis	(leukocyte	count	>	15,000	mm3),	
intra-amniotic	 infection	 indicated	 by	 amniotic	 fluid	 culture,	
maternal	body	temperature	exceeding	37.8°C,	and	patients	aged	
below	17	years	or	above	45	years.	Ethical	approval	was	received	
from	the	ethics	committee	of	Ondokuz	Mayıs	University	and	all	
participants	gave	informed	signed	consent.	
Pelvic	examination	was	performed	using	a	sterile	speculum	
(Simpson	 speculum)	 for	 all	 pregnant	 women	 in	 the	 study	 and	
control	groups,	and	vaginal	and	cervical	status	was	evaluated.	A	
study	 information	 form	was	 issued	 to	 all	 pregnant	women	 and	
patient	details	(age,	body	weight,	gravidity,	parity,	abortion,	live	
children,	 examination	 findings,	 current	 medications,	 Bishop’s	
score,	vital	findings,	and	laboratory	examinations)	were	recorded.
2. Maternal Serum
Maternal	 serum	 samples	 were	 obtained	 from	 7–8	 mL	 of	
whole	 blood	 drawn	with	 a	 10	mL	 syringe	 via	 puncture	 of	 the	
antecubital	veins	at	room	temperature	(24°C)	in	a	sitting	position	
and	 irrespective	 of	 fasting	 status.	 Whole	 blood	 samples	 were	
centrifuged	at	5000	rpm	for	5	minutes	at	4°C	within	1	hour	of	
collection	in	order	to	separate	serum	after	blood	clotting.	Serum	
samples	were	 stored	at	 -30°C	 to	allow	study	once	an	adequate	
number	of	patients	were	enrolled.
3. IL-6 Immunoassay
The	IL-6	levels	of	maternal	serum	samples	were	determined	
via	solid	phase	enzyme	amplified	sensitivity	immunoassay	using	
a	commercial	kit	(DioSource	Europa	SA,	Nivelles,	Belgium)	in	
accordance	 with	 the	 procedure	 specified	 by	 the	 manufacturer.	
Enzymatic	 reaction	 was	 evaluated	 with	 an	 automated	 micro-
plate	reader.	Results	were	expressed	as	pg/mL.	The	lower	cut-off	
value	of	the	IL-6	kit	was	2.0	pg/mL.	The	inter-assay	coefficient	
of	variation	 (CV)	was	4.4%	and	 the	 intra-assay	CV	was	4.2%.	
Samples	with	high	values	were	diluted	and	repeated.	
4. Statistical Analysis
Statistical	analyses	were	performed	using	SPSS	for	Windows	
version	15.0	software.	Data	were	expressed	as	mean	and	median.	
Inter-group	comparisons	were	made	with	Student’s	t-test,	Mann-
Whitney	test,	Fisher’s	exact	test,	and	Chi-square	test.	A	P	value	
below	0.05	was	considered	statistically	significant.	
Results
The	 age	 distribution	 of	 the	 study	 group	 ranged	 between	
17	 years	 and	 40	 years	 (median:	 27.5	 years),	 while	 the	 age	
distribution	of	the	controls	ranged	between	22	years	and	45	years	
(median:	 30.5	 years).	 In	 the	 study	 group,	 gestation	 age	 ranged	
from	24	weeks	and	4	days	to	34	weeks	and	6	days.	For	the	control	
group,	gestational	age	was	between	26	weeks	and	5	days	and	34	
weeks	and	6	days.	There	was	a	statistically	significant	difference	
between	the	study	and	control	groups	in	terms	of	age	and	body	
weight,	while	there	was	no	difference	in	terms	of	gravidity	and	
gestational	week.	(Table	I).
Parenteral	fluid	therapy	was	started	in	all	22	pregnant	women	
in	the	study	group.	Of	these	22	women,	13	(59%)	were	started	on	
pharmacologic	tocolytic	therapy.	Twelve	of	the	13	women	(92%)	
had	 tocolysis	with	nifedipine,	while	 1	 (8%)	had	 tocolysis	with	
ritodrine.
Of	the	22	pregnant	women	with	diagnosis	of	preterm	labor	in	
the	study	group,	11	(50%)	underwent	preterm	delivery.	Of	these	
11	women,	8	(72.2%)	had	caesarean	section	and	3	(27.8%)	had	
spontaneous	 vaginal	 delivery.	 For	 the	 8	 pregnant	 women	who	
underwent	 caesarean	 section,	 delivery	was	 completed	within	 7	
days	 in	5	women	(62.5%),	while	 it	exceeded	7	days	(8	days,	9	
days,	and	28	days)	in	3	women	(37.5%).
Considering	 the	 3	 pregnant	 women	 who	 had	 spontaneous	
vaginal	 delivery,	 1	 (33.4%)	 delivered	within	 7	 days,	while	 the	
delivery	 period	 exceeded	 7	 days	 (18	 days	 and	 28	 days)	 in	 2	
women	 (66.6%).	One	 pregnant	woman	 in	 the	 study	 group	 had	
diagnosis	of	chronic	hypertension	without	attacks	and	significant	
proteinuria.
As	 compared	 to	 the	 control	 group,	 the	 maternal	 serum	
levels	 of	 IL-6	 in	 the	 preterm	 labor	 group	 were	 elevated.	 The	
mean	maternal	serum	level	of	IL-6	was	47.0	±	15.4	pg/mL	in	the	
preterm	labor	group	and	23.6	±1.6	pg/mL	in	the	control	group.	
Although	maternal	 serum	 IL-6	 levels	were	 found	 to	 be	 higher	
in	 patients	with	 preterm	 labor	when	 compared	 to	 controls	 this	
difference	was	statistically	insignificant	(P	>	0.05).	(Table	II).	
Table I. Comparison of study and control groups in terms of maternal particularities.
Study Group
N=22
Control Group
N=22 P
(significance)Mean±SD
(Median)
Mean±SD
(Median)
Age  
(years)
26.7±1.27
(27.5)
30.7±1.21
(30.5) 0.026*
Body weight  
(kg)
66.2±2.21
(68.5)
73.3±2.44
(70.5) 0.037*
Gestational week 32.5±0.61(33.7)
31.6±0.53
(32.3) 0.095
History of preterm delivery 1 (%4.5) 0 (%0) 1
History of habitual abortus 2 (%9.1) 0.488
*p<0.05 is significant
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Interestingly,	 comparison	 of	 maternal	 serum	 IL-6	 levels	
in	patients	who	delivered	within	7	days	and	 those	who	did	not	
showed	 that,	 although	 statistically	 insignificant,	 patients	 who	
delivered	within	7	days	after	the	diagnosis	of	preterm	labor	had	
lower	serum	levels	of	IL-6	(P	>	0.05).	(Table	III).
Discussion
Preterm	 delivery	 is	 still	 an	 important	 obstetric	 problem	 in	
both	developed	and	developing	countries.	Preterm	deliveries	are	
a	significant	cause	of	neonatal	mortality	and	morbidity.	Despite	
efforts	to	prevent	preterm	delivery,	difficulties	in	understanding	
the	 underlying	 pathology,	 insufficient	 diagnostic	 methods,	
and	non-efficient	 treatment	methods	have	 led	 to	 an	 increase	 in	
preterm	delivery	rates	over	the	last	2	decades	in	many	developed	
countries	 [10].	 In	 this	 study,	 serum	 IL-6	 was	 studied	 and	 its	
relationship	with	preterm	labor	was	examined.	
While	some	have	found	significant	association	between	many	
pro-inflammatory	 cytokines,	 including	 IL-6,	 and	 spontaneous	
preterm	 labor	 [11,	 12,	 13,	 14,	 15],	 others	 have	 found	 no	 such	
association	[16,	17].	In	a	randomized,	controlled	and	multi-center	
study	involving	475	patients,	 it	was	determined	that	 in	patients	
with	 diagnosis	 of	 preterm	 labor	 in	 gestational	 weeks	 24–32,	
elevated	IL-6	and	C	reactive	protein	(CRP)	levels	causes	increased	
risk	for	preterm	labor	and	neonatal	intra-ventricular	hemorrhage.	
Moreover,	for	pregnant	women	complicated	with	preterm	labor	
or	 PPROM,	 a	 consistent	 relationship	 was	 determined	 between	
elevated	maternal	serum	IL-6,	CRP,	and	matrix	metalloproteinase	
(MMP)-9	levels	[1].
In	 an	 infection-induced	mouse	model	 of	 preterm	 delivery,	
acute	 administration	 of	 recombinant	 IL-6	 did	 not	 result	 in	
significant	shortening	of	gestation	and	the	authors	concluded	that	
IL-6	has	a	limited	biological	role	in	preterm	labor	[18].	In	contrast	
to	this	study,	by	using	IL-6-deficient	animals,	it	was	shown	that	
IL-6	deficiency	results	in	delayed	normal	timing	of	delivery	[19].	
In	 the	 present	 study,	 although	 maternal	 serum	 levels	 of	 IL-6	
were	 found	 to	 be	 higher	 in	 patients	 with	 preterm	 labor,	 there	
was	 no	 statistically	 significant	 difference	 in	 serum	 IL-6	 levels	
between	the	study	and	control	groups.	This	finding	may	indicate	
that	 significant	 increases	 in	 serum	 IL-6	 levels	 occur	 secondary	
to	 overt	 infection,	 since	 patients	 with	 clinical	 or	 biochemical	
infection	 signs	were	 not	 included	 in	 the	 current	 study.	 Studies	
conducted	on	this	subject	in	the	literature	state	that	IL-6	largely	
increases	secondary	to	infection	[9].	
It	 has	 also	been	 stated	 that	women	with	maternal	 signs	of	
infection	have	significantly	higher	IL-6	levels	than	women	with	
no	signs	of	infection	[20].	In	a	systemic	review	on	the	association	
between	 inflammatory	 cytokines	 and	 the	 risk	 of	 spontaneous	
preterm	 birth	 in	 asymptomatic	 women,	 the	 authors	 concluded	
that	IL-6	in	cervicovaginal	fluid	and	IL-6	and	CRP	in	amniotic	
fluid	but	not	in	plasma	were	strongly	associated	with	spontaneous	
preterm	birth,	suggesting	that	inflammation	at	the	maternal-fetal	
interface,	rather	than	systemic	inflammation,	may	be	important	in	
the	occurrence	of	preterm	birth	[21].	
Conclusion
In	conclusion,	in	patients	with	preterm	labor	not	associated	
with	infection,	no	significant	relationship	was	identified	between	
Table II. Comparison of study and control groups in terms of maternal serum IL–6   and white blood cell count. 
 
Study Group
N=22 
Control Group
N=22 P
(significance) Mean±SD
(Median)
Mean±SD
(Median)
Interleukin–6  
(pg/mL)
47.0±15.4
(23.1)
23.6±1.6
(22.1) 0.605
White blood cell count  
(mm³)
11937,2±769.81
(10675.0)
9526.3±493.2
(9950.0) 0.024
*p<0.05 is significant
Table III. Comparison of maternal serum IL–6 levels of patients in study group in terms of preterm delivery in one week.  
Preterm labor
group delivered in one week after 
diagnosis of preterm labor (n=6)    
Preterm labor
group not delivered in one week after 
diagnosis of preterm labor (n=16) 
P
(significance) 
Mean±SD Mean±SD
İnterlökin-6  
(pg/mL)
24.1±17.4
(17.1)
57.7±22.1
(23.1) 0.185
White blood cell count  
(mm³)
11568.57±1421
(10480.0)
12109.3±945
(11700.0) 0.582
*p<0.05 is significant
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IL-6	 and	 preterm	 labor.	 Infection	 and/or	 inflammation	 are	 the	
only	known	pathological	processes	in	the	development	of	preterm	
labor	and	birth	[22].	An	increase	in	pro-inflammatory	cytokines	
during	 fetal	 infection	 and	 fetal	HPA	activation	 are	 2	 important	
mechanisms	in	the	etiology	of	preterm	birth	[9].
Further	studies	may	be	beneficial	in	order	to	determine	whether	
inflammatory	cytokines	increase	following	primary	inflammation	
and/or	clinically	overt	infection.	Better	understanding	of	the	role	
of	 inflammatory	 cytokines	 in	 preterm	 birth	may	 lead	 to	 future	
development	of	treatment	strategies	to	prevent	the	inflammatory	
activation	involved	in	preterm	birth.	
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